A hybrid modeling framework to optimize Chinese hamster ovary cell cultures for monoclonal antibody (mAb) production reduces the number of modeling parameters needed while returning results that ...

What would a Tesla be without controversy and split opinions? The Tesla Model Y’s midcycle refresh brought significant enough changes to earn it a spot in our 2026 SUV of the Year competition. The ...

It’s October and fashion week is over, but airbrush artist Mab is still hellbent on couture. On Saturday night, the artist—known for airbrushing abs at Theophilio’s SS26 show—hosted her first-ever ...

I-Mab (NASDAQ:IMAB) shares fell ~14% on Friday after the cancer drug developer announced a new “hub-and-spoke” business model, under which it plans to seek a name change and a potential dual listing ...

Less than two years after laying out plans to divest its China operations and become a U.S.-focused biotech, I-Mab Biopharma is re-staking its claim in the Asia-Pacific region. The drugmaker mapped ...

New business model reflects strategic transition to a global biotech platform focused on business development and translational clinical development to accelerate access to innovative medicines for ...

At a time when it feels like everything is getting more expensive by the hour, it's refreshing to see an automaker roll out more affordable models. That's exactly what happened in Texas this week, ...

I-Mab has pivoted to focus on givastomig for gastric cancer after divesting its original China portfolio and revamping leadership. Givastomig shows superior early efficacy versus rivals, with ...

South Africa’s Black woman-founded S.MAB Group appoints new CEO, keeping leadership in women’s hands. South Africa’s pioneering Black woman-founded S.MAB Group has appointed a new CEO, continuing its ...

Buying an electric car is all about driving range, and the Long Range RWD and Long Range AWD models offer up to 337 and 311 miles of range, respectively. We'd go with the Long Range with the ...

ICICI Bank faced widespread criticism after announcing a significant increase in minimum balance requirements for new account holders. Consequently, the bank rolled back the decision and revised its ...

I-Mab acquires Bridge Health, gaining upstream rights to CLDN18.2 antibody, reducing milestone payments for givastomig and eliminating royalties. I-Mab has announced its acquisition of Bridge Health ...